// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























2187 Abstracts

CYTOKINES TGFΒ1, TNF AND PHAGOCYTOSIS IN PERIPHERAL BLOOD (PB) OF ADULT PATIENTS (PTS) WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AS MARKERS OF SPREAD DISEASES

Vira Barilka - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Acute lymphoblastic leukemia

Hypaque Injection

THERAPEUTIC POTENTIAL OF PIMOZIDE IN ACUTE LYMPHOBLASTIC LEUKEMIA CELL LINES

Joana Jorge - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

Pimozide

11Q23/MLL REARRANGEMENTS IN ADULT ACUTE LEUKEMIA

Olena Zotova - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Acute lymphoblastic leukemia

N/A

GENETIC VARIANT OF TUMOR NECROSIS FACTOR-Α AND INTERLEUKIN-10 IN CHILDHOOD AND ADULT ACUTE LYMPHOBLASTIC LEUKEMIA

Mohamed Elbaiomy - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

Interleukin-10

OUTCOME OF ASPARAGINASE ASSOCIATED PANCREATITIS IN EGYPTIAN CHILDREN TREATED FOR ACUTE LYMPHOBLASTIC LEUKEMIA

Sara Makkeyah - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Acute lymphoblastic leukemia

Asparaginase

RISK FACTORS AND OUTCOMES OF CENTRAL NERVOUS SYSTEM RELAPSE IN HISPANIC ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Roberta Demichelis - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

CHILDHOOD AND ADOLESCENTS-YOUNG ADULTS T ACUTE LYMPHOBLASTIC LEUKEMIA IN SOUTH OF TUNISIA

Imen Frikha - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

A SIMPLE PROGNOSTIC SCORE PREDICTS MORTALITY IN PATIENTS NEWLY DIAGNOSED WITH ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA (ALL/LL)

Ana Vagos Mata - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

HIGH-HYPERDIPLOIDY CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: CYTOGENETIC,CLINICAL AND PROGNOSTIC IMPLICATIONS

Maria Kourti - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

RESULTS OF COOPRALL 2007 PROTOCOL IN THE TREATMENT OF FIRST RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA

Ines Turki - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

CLINICAL CHARACTERISTICS AND SURVIVAL IMPACT OF ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS WITH 11Q23 REARRANGEMENT FROM A REFERENCE CENTER IN MEXICO.

Cynthia Pelayo - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

CLINICAL, CYTOGENETIC AND IMMUNOPHENOTYPIC FEATURES OF CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND POSITIVE TEL-AML 1 FUSION GENE

Maria Kourti - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

NONHEMATOLOGIC TOXICITY OF IMATINIB MESYLATE IN PEDIATRIC PATIENT WITH PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE REPORT

Pio Stellato - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Acute lymphoblastic leukemia

Imatinib

SEIZURE AS A RARE SIDE EFFECT OF L-ASPARAGINASE INFUSION IN A LEUKEMIC CHILD WITH DOWN SYNDROME

Veysel GOK - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

Methylprednisolone

SYNDECAN-1 AS A PROGNOSTIC BIOMARKER IN ACUTE MYELOID LEUKEMIA

Reham Alghandour - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Acute lymphoblastic leukemia

N/A

COMPARISON OF FOUR FLOW CYTOMETRY METHODS FOR CART-19 DETECTION IN B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA PAEDIATRIC PATIENTS

Sandra Pont Mart - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

tisagenlecleucel-t

HIGH PREVALENCE OF METABOLIC, ENDOCRINE AND BONE DISEASE IN HISPANIC SURVIVORS OF ACUTE LEUKEMIA

Alfonso Orozco Collazo - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Acute lymphoblastic leukemia

N/A

TYPE OF VENTILATORY SUPPORT AS AN INDEPENDENT PROGNOSTIC FACTOR IN CRITICALLY ILL HEMATOLOGIC MALIGNANCIES PATIENTS

Ana Carolina Oliver - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Acute lymphoblastic leukemia

N/A

DIAGNOSIS OF ACUTE LEUKEMIA AND ITS IMPACT IN A RESOURCE POOR CENTRE OF EASTERN INDIA: A RETROSPECTIVE OVERVIEW

Debmalya Bhattacharyya - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Acute lymphoblastic leukemia

N/A

LOSS OF HEPATITIS B CORE ANTIBODIES EARLY IN ALLO-HSCT MAY HELP PREDICT PROGNOSIS IN PATIENTS WITH HBSAG-NEGATIVE/ANTI-HBC-POSITIVE: A SINGLE-CENTER OBSERVATIONAL STUDY OF 141 PATIENTS

Jinhua Ren - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Acute lymphoblastic leukemia

Entecavir

Copyright © 2026. QuantiNova All rights reserved